Single-cell sequencing reveals novel cellular heterogeneity in uterine leiomyomas.
MED12
cellular heterogeneity
myometrium
single-cell RNA sequencing
uterine leiomyomas
Journal
Human reproduction (Oxford, England)
ISSN: 1460-2350
Titre abrégé: Hum Reprod
Pays: England
ID NLM: 8701199
Informations de publication
Date de publication:
30 09 2022
30 09 2022
Historique:
received:
17
02
2022
revised:
29
06
2022
pubmed:
25
8
2022
medline:
5
10
2022
entrez:
24
8
2022
Statut:
ppublish
Résumé
What are the cellular composition and single-cell transcriptomic differences between myometrium and leiomyomas as defined by single-cell RNA sequencing? We discovered cellular heterogeneity in smooth muscle cells (SMCs), fibroblast and endothelial cell populations in both myometrium and leiomyoma tissues. Previous studies have shown the presence of SMCs, fibroblasts, endothelial cells and immune cells in myometrium and leiomyomas. However, there is no information on the cellular heterogeneity in these tissues and the transcriptomic differences at the single-cell level between these tissues. We collected five leiomyoma and five myometrium samples from a total of eight patients undergoing hysterectomy. We then performed single-cell RNA sequencing to generate a cell atlas for both tissues. We utilized our single-cell sequencing data to define cell types, compare cell types by tissue type (leiomyoma versus myometrium) and determine the transcriptional changes at a single-cell resolution between leiomyomas and myometrium. Additionally, we performed MED12-variant analysis at the single-cell level to determine the genotype heterogeneity within leiomyomas. We collected five MED12-variant positive leiomyomas and five myometrium samples from a total of eight patients. We then performed single-cell RNA sequencing on freshly isolated single-cell preparations. Histopathological assessment confirmed the identity of the samples. Sanger sequencing was performed to confirm the presence of the MED12 variant in leiomyomas. Our data revealed previously unknown heterogeneity in the SMC, fibroblast cell and endothelial cell populations of myometrium and leiomyomas. We discovered the presence of two different lymphatic endothelial cell populations specific to uterine leiomyomas. We showed that both myometrium and MED12-variant leiomyomas are relatively similar in cellular composition but differ in cellular transcriptomic profiles. We found that fibroblasts influence the leiomyoma microenvironment through their interactions with endothelial cells, immune cells and SMCs. Variant analysis at the single-cell level revealed the presence of both MED12 variants as well as the wild-type MED12 allele in SMCs of leiomyomatous tissue. These results indicate genotype heterogeneity of cellular composition within leiomyomas. The datasets are available in the NCBI Gene Expression Omnibus (GEO) using GSE162122. Our study focused on MED12-variant positive leiomyomas for single-cell RNA sequencing analyses. Leiomyomas carrying other genetic rearrangements may differ in their cellular composition and transcriptomic profiles. Our study provides a cellular atlas for myometrium and MED12-variant positive leiomyomas as defined by single-cell RNA sequencing. Our analysis provides significant insight into the differences between myometrium and leiomyomas at the single-cell level and reveals hitherto unknown genetic heterogeneity in multiple cell types within human leiomyomas. Our results will be important for future studies into the origin and growth of human leiomyomas. This work was supported by funding from the National Institute of Child Health and Human Development (HD098580 and HD088629). The authors declare no competing interests.
Identifiants
pubmed: 36001050
pii: 6674607
doi: 10.1093/humrep/deac183
pmc: PMC9802286
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
2334-2349Subventions
Organisme : NICHD NIH HHS
ID : P50 HD098580
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD088629
Pays : United States
Informations de copyright
© The Author(s) 2022. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Références
Hum Reprod Update. 2015 Sep-Oct;21(5):593-615
pubmed: 26141720
Obstet Gynecol. 2002 Feb;99(2):229-34
pubmed: 11814502
Genome Biol. 2019 Dec 23;20(1):296
pubmed: 31870423
Br J Cancer. 2016 Jun 14;114(12):1405-11
pubmed: 27187686
Dev Biol. 2005 Dec 1;288(1):276-83
pubmed: 16256976
PLoS One. 2012;7(3):e33251
pubmed: 22428002
Cell. 2019 Jun 13;177(7):1888-1902.e21
pubmed: 31178118
J Clin Pathol. 2005 Feb;58(2):202-6
pubmed: 15677543
Oncotarget. 2011 Dec;2(12):966-9
pubmed: 22182697
Hum Reprod. 1999 Jan;14(1):229-36
pubmed: 10374126
Reproduction. 2014 Apr 08;147(5):683-92
pubmed: 24713395
Mol Cell Probes. 1997 Jun;11(3):217-28
pubmed: 9232621
Lancet. 2001 Jan 27;357(9252):293-8
pubmed: 11214143
Dev Biol. 2000 Feb 15;218(2):183-98
pubmed: 10656762
Mol Endocrinol. 2013 Sep;27(9):1403-14
pubmed: 23820898
Cancer Res. 2017 Nov 1;77(21):e31-e34
pubmed: 29092934
Genes Chromosomes Cancer. 1994 Sep;11(1):1-6
pubmed: 7529041
Am J Obstet Gynecol. 1965 Feb 1;91:413-8
pubmed: 14258269
Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):2187-92
pubmed: 23284171
Nat Rev Dis Primers. 2016 Jun 23;2:16043
pubmed: 27335259
Placenta. 2008 Mar;29 Suppl A:S55-9
pubmed: 18155143
Hum Reprod. 1997 Feb;12(2):368-72
pubmed: 9070727
Eur Heart J. 2015 Jun 1;36(21):1335-45
pubmed: 24419809
Nat Commun. 2021 Feb 17;12(1):1088
pubmed: 33597522
Mol Cell Endocrinol. 2012 Jul 25;358(2):223-31
pubmed: 21672608
Curr Biol. 2009 Jul 14;19(13):R504-7
pubmed: 19602408
Mol Genet Genomics. 2015 Apr;290(2):505-11
pubmed: 25325994
Science. 2011 Oct 14;334(6053):252-5
pubmed: 21868628
Nat Biotechnol. 2018 Jun;36(5):411-420
pubmed: 29608179
N Engl J Med. 2013 Oct 3;369(14):1344-55
pubmed: 24088094
Fertil Steril. 2011 Jan;95(1):9-12
pubmed: 20883986
Mol Hum Reprod. 2014 Mar;20(3):250-9
pubmed: 24243625
Nat Commun. 2020 Feb 24;11(1):1019
pubmed: 32094355
Am J Obstet Gynecol. 2012 Mar;206(3):211.e1-9
pubmed: 22244472
Genome Biol. 2016 Feb 17;17:29
pubmed: 26887813
Blood. 2012 Mar 29;119(13):e100-9
pubmed: 22286197
Biol Reprod. 2009 Sep;81(3):545-52
pubmed: 19403928
Curr Top Dev Biol. 2017;125:171-190
pubmed: 28527571
Science. 1965 Oct 1;150(3692):67-9
pubmed: 5833538
Nat Biotechnol. 2011 Jan;29(1):24-6
pubmed: 21221095
Nat Biotechnol. 2018 Jan;36(1):89-94
pubmed: 29227470
J Clin Invest. 2015 Aug 3;125(8):3280-4
pubmed: 26193636
Nature. 2005 Apr 14;434(7035):843-50
pubmed: 15829953
J Genomics. 2015 Jan 01;3:1-19
pubmed: 25628761
N Engl J Med. 2013 Jul 4;369(1):43-53
pubmed: 23738515
Front Immunol. 2019 Jan 25;10:36
pubmed: 30740101
Mol Hum Reprod. 1998 Jan;4(1):83-6
pubmed: 9510016
Data Brief. 2017 Apr 08;12:208-212
pubmed: 28443299
Elife. 2019 Dec 12;8:
pubmed: 31829938
Cancer Res. 2017 Dec 15;77(24):6891-6901
pubmed: 29055020
Nature. 2005 Mar 17;434(7031):400-4
pubmed: 15772666
J Clin Invest. 2014 Mar;124(3):936-42
pubmed: 24590279
Oncotarget. 2017 May 23;8(21):34762-34772
pubmed: 28410233
Fertil Steril. 2017 Feb;107(2):457-466.e9
pubmed: 27889101